170 related articles for article (PubMed ID: 18536748)
1. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.
Bosier B; Hermans E; Lambert D
Br J Pharmacol; 2008 Sep; 155(1):24-33. PubMed ID: 18536748
[TBL] [Abstract][Full Text] [Related]
2. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
Bosier B; Hermans E; Lambert DM
Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
[TBL] [Abstract][Full Text] [Related]
3. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
4. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
5. Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line.
Bosier B; Tilleux S; Najimi M; Lambert DM; Hermans E
J Neurochem; 2007 Sep; 102(6):1996-2007. PubMed ID: 17540007
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells.
Bosier B; Lambert DM; Hermans E
FEBS Lett; 2008 Nov; 582(28):3861-7. PubMed ID: 18950629
[TBL] [Abstract][Full Text] [Related]
7. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.
Blume LC; Eldeeb K; Bass CE; Selley DE; Howlett AC
Cell Signal; 2015 Mar; 27(3):716-726. PubMed ID: 25446256
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.
Scotter EL; Goodfellow CE; Graham ES; Dragunow M; Glass M
Br J Pharmacol; 2010 Jun; 160(3):747-61. PubMed ID: 20590577
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
Ahn KH; Mahmoud MM; Kendall DA
J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
[TBL] [Abstract][Full Text] [Related]
13. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
[TBL] [Abstract][Full Text] [Related]
14. Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors.
Redmond WJ; Cawston EE; Grimsey NL; Stuart J; Edington AR; Glass M; Connor M
Br J Pharmacol; 2016 Jan; 173(1):115-27. PubMed ID: 26398720
[TBL] [Abstract][Full Text] [Related]
15. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
Dhopeshwarkar AS; Nicholson RA
Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
[TBL] [Abstract][Full Text] [Related]
16. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
18. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
Dalton VS; Zavitsanou K
Synapse; 2010 Nov; 64(11):845-54. PubMed ID: 20842718
[TBL] [Abstract][Full Text] [Related]
20. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
